CX Institutional’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $451K | Buy |
6,271
+1,858
| +42% | +$175K | 0.01% | 499 |
|
|
2026
Q1 | $522K | Buy |
4,413
+258
| +6% | +$31.9K | 0.02% | 451 |
|
|
2025
Q4 | $523K | Buy |
4,155
+2,264
| +120% | +$295K | 0.02% | 412 |
|
|
2025
Q3 | $277K | Sell |
1,891
-1,067
| -36% | -$161K | 0.01% | 596 |
|
|
2025
Q2 | $461K | Sell |
2,958
-1,227
| -29% | -$195K | 0.02% | 387 |
|
|
2025
Q1 | $689K | Sell |
4,185
-3,117
| -43% | -$518K | 0.03% | 323 |
|
|
2024
Q4 | $1.19M | Sell |
7,302
-840
| -10% | -$150K | 0.05% | 231 |
|
|
2024
Q3 | $1.59M | Buy |
8,142
+482
| +6% | +$88.8K | 0.07% | 216 |
|
|
2024
Q2 | $1.33M | Buy |
7,660
+834
| +12% | +$139K | 0.06% | 238 |
|
|
2024
Q1 | $1.16M | Sell |
6,826
-644
| -9% | -$121K | 0.06% | 261 |
|
|
2023
Q4 | $1.47M | Sell |
7,470
-341
| -4% | -$60.4K | 0.08% | 211 |
|
|
2023
Q3 | $1.36M | Sell |
7,811
-5,365
| -41% | -$974K | 0.07% | 220 |
|
|
2023
Q2 | $2.27M | Buy |
13,176
+138
| +1% | +$23.9K | 0.12% | 202 |
|
|
2023
Q1 | $2.18M | Buy |
13,038
+10,240
| +366% | +$1.68M | 0.12% | 210 |
|
|
2022
Q4 | $410K | Buy |
2,798
+1,190
| +74% | +$176K | 0.02% | 393 |
|
|
2022
Q3 | $238K | Buy |
1,608
+128
| +9% | +$21.4K | 0.02% | 421 |
|
|
2022
Q2 | $254K | Sell |
1,480
-279
| -16% | -$48.3K | 0.02% | 402 |
|
|
2022
Q1 | $332K | Buy |
1,759
+130
| +8% | +$25.7K | 0.03% | 303 |
|
|
2021
Q4 | $398K | Sell |
1,629
-1,706
| -51% | -$374K | 0.03% | 262 |
|
|
2021
Q3 | $647K | Sell |
3,335
-9,160
| -73% | -$1.85M | 0.05% | 233 |
|
|
2021
Q2 | $2.33M | Buy |
12,495
+301
| +2% | +$52.3K | 0.19% | 131 |
|
|
2021
Q1 | $1.92M | Buy |
12,194
+11,128
| +1,044% | +$1.76M | 0.17% | 157 |
|
|
2020
Q4 | $176K | Sell |
1,066
-142
| -12% | -$23.1K | 0.02% | 299 |
|
|
2020
Q3 | $200K | Buy |
1,208
+267
| +28% | +$41K | 0.02% | 261 |
|
|
2020
Q2 | $129K | Buy |
941
+211
| +29% | +$27.5K | 0.02% | 264 |
|
|
2020
Q1 | $86K | Buy |
730
+10
| +1% | +$1.32K | 0.01% | 277 |
|
|
2019
Q4 | $95K | Hold |
720
| – | – | 0.02% | 239 |
|
|
2019
Q3 | $90K | Buy |
720
+15
| +2% | +$1.81K | 0.01% | 258 |
|
|
2019
Q2 | $80K | Buy |
705
+11
| +2% | +$1.15K | 0.01% | 290 |
|
|
2019
Q1 | $70K | Buy |
694
+186
| +37% | +$16.9K | 0.01% | 308 |
|
|
2018
Q4 | $43K | Buy |
508
+21
| +4% | +$1.89K | 0.01% | 271 |
|
|
2018
Q3 | $45K | Hold |
487
| – | – | 0.01% | 198 |
|
|
2018
Q2 | $41K | Buy |
+487
| New | +$41.1K | 0.02% | 167 |
|
Other funds holding ZTS
CX Institutional's ZTS Position: Q2 2026 in Review
CX Institutional increased its Zoetis (ZTS) stake by 42% in Q2 2026, buying an estimated $175K and bringing the position to 6,271 shares worth $451K. The position accounts for 0.01% of the portfolio, ranked #499.
CX Institutional first reported a position in ZTS in Q2 2018 and has held it in 33 quarters since. The position peaked at $2.33M in Q2 2021. 1,427 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.
- CX Institutional held 6,271 shares of Zoetis worth $451K as of Q2 2026.
- CX Institutional bought 1,858 Zoetis shares in Q2 2026, an estimated $175K.
- Zoetis made up 0.01% of CX Institutional's portfolio in Q2 2026, its #499 holding.
- CX Institutional first reported a position in Zoetis in Q2 2018 and has held it in 33 quarters since.
- CX Institutional's Zoetis position peaked at $2.33M in Q2 2021.
- 1,427 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.
Based on CX Institutional's 13F filing for Q2 2026, filed 2 Jul 2026.